Aerpio Pharmaceuticals (NASDAQ:ARPO) reported quarterly losses of $(0.09) per share. This is a 139.13 percent decrease over earnings of $0.23 per share from the same period last year.
Aerpio Pharmaceuticals Q2 EPS $(0.09) Down From $0.23 YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.